CDC Health Alert Network (HAN) Info Service Message: Non-Safety-Related Voluntary Recall of Unused Doses from Certain Lots of Sanofi Pasteur H1N1 Vaccine in Pre-Filled Syringes
Published Feb. 1, 2010 at 5:45 p.m.
As of January 7, 2010, the cumulative pro rata allocation is approximately 136 million doses of 2009 H1N1 vaccine. As of January 5, 2010, approximately 111 million doses have been shipped, so supplies of 2009 H1N1 vaccine available to be administered are ample. Although the 2009 H1N1 vaccine was initially prioritized to certain target groups, due to the increase in supply most jurisdictions are now making vaccine available for everyone who wishes to receive it.
This site was created to help deal with the H1N1 influenza flu pandemic. Flu preparation is important! You can have an immunization with the flu vaccine, you can have the flu shot; flu shots are good before you are showing flu symptoms, although the current trivalent influenza vaccine is unlikely to provide protection against the new 2009 H1N1 strain, vaccines against the new strain are being developed and could be ready as early as June 2009.
According to the Centers for Disease Control and Prevention (CDC), in humans the symptoms of H1N1 swine flu are similar to those of influenza and of influenza-like illness in general. Symptoms include fever, cough, sore throat, body aches, headache, chills and fatigue. The 2009 outbreak has shown an increased percentage of patients reporting diarrhea and vomiting.
Recommendations to prevent the spread of the virus among humans include using standard infection control against influenza. This includes frequent washing of hands with soap and water or with alcohol-based hand sanitizers, especially after being out in public.